Electromed (ELMD) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.52% |
| Dec 31, 2025 | 18.54% |
| Sep 30, 2025 | 33.07% |
| Jun 30, 2025 | 19.57% |
| Mar 31, 2025 | 19.23% |
| Dec 31, 2024 | 10.93% |
| Sep 30, 2024 | 8.96% |
| Jun 30, 2024 | 10.41% |
| Mar 31, 2024 | 31.86% |
| Dec 31, 2023 | 27.82% |
| Sep 30, 2023 | 0.35% |
| Jun 30, 2023 | 3.49% |
| Mar 31, 2023 | 16.13% |
| Dec 31, 2022 | 10.84% |
| Sep 30, 2022 | -12.75% |
| Jun 30, 2022 | -19.82% |
| Mar 31, 2022 | -3.30% |
| Dec 31, 2021 | 8.67% |
| Sep 30, 2021 | 14.98% |
| Jun 30, 2021 | 4.43% |
| Mar 31, 2021 | -18.93% |
| Dec 31, 2020 | 5.28% |
| Sep 30, 2020 | 3.53% |
| Jun 30, 2020 | 27.40% |
| Mar 31, 2020 | 91.04% |
| Dec 31, 2019 | 30.57% |
| Sep 30, 2019 | 29.75% |
| Jun 30, 2019 | 34.83% |
| Mar 31, 2019 | 32.26% |
| Dec 31, 2018 | 32.65% |
| Sep 30, 2018 | 18.77% |
| Jun 30, 2018 | 36.67% |
| Mar 31, 2018 | 22.87% |
| Dec 31, 2017 | 26.45% |
| Sep 30, 2017 | 22.10% |
| Jun 30, 2017 | 55.70% |
| Mar 31, 2017 | 41.21% |
| Dec 31, 2016 | 66.05% |
| Sep 30, 2016 | -7.80% |
| Jun 30, 2016 | 7.34% |
| Mar 31, 2016 | 2.67% |
| Dec 31, 2015 | 20.25% |
| Sep 30, 2015 | 24.61% |